A Randomised Phase III Clinical Trial Comparing Surgery Alone with Concurrent Preoperative Chemotherapy and Radiation Followed by Surgery For Localised Resectable Carcinoma of the Oesophagus
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Collaborating Groups
Australasian Gastro-Intestinal Cancer Trials Group (AGITG)
Related Post
26 September, 2026
Trial finds radiation therapy halves risk of brain tumour recurrence after surgery
LATEST NEWS: 26 September 2026 Giving radiotherapy after surgery
17 September, 2026
Meet the TROG Quality Assurance team
TROG UPDATES: 17 September 2026 Our Quality Assurance team